From: Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
S-L | ICHD-3β | n (%) | EO | n (%) |
---|---|---|---|---|
n = 261 | 185 (70.9 %) | 261 (100 %) | ||
MO, n = 183 | MO | 177 (96.7 %) | MO | 183 (100 %) |
MA, n = 8 | MA | 8 (100 %) | MA | 8 (100 %) |
PM, n = 70 | – | – | PM | 70 (100 %) |